TL;DR
Noom has launched a new GLP-1Rx program that offers access to prescription medications such as Ozempic, integrated with its psychological support system. The program aims to support sustainable weight loss and is available starting at $99 for those who qualify. The initiative combines medication, behavioral coaching, and community support.
Noom has officially launched its GLP-1Rx program, offering qualified users access to prescription medications such as Ozempic and Zepbound, combined with its established behavioral support system. This move marks a significant expansion of Noom’s weight management offerings, integrating medication with its psychology-based approach to support sustainable weight loss.
The program, developed by medical professionals, provides access to brand-name GLP-1 medications starting at $99 for qualifying individuals. It includes personalized treatment plans, ongoing medication management, and access to licensed clinicians, behavior change coaches, and community groups. The program also features Noom’s GLP-1 Companion, a digital support tool offering resources on medication use, nutrition, side effects, and body tracking, which has been shown to improve weight loss outcomes.
According to Noom, most engaged users of the GLP-1 Companion achieve approximately 25% more weight loss than less engaged participants. The program emphasizes a holistic approach, aiming to help users keep muscle, lose fat, develop healthy habits, and sustain long-term results. The medications available include popular options like Ozempic, with prices starting at $69 plus out-of-pocket costs, depending on insurance coverage.
Impact of Noom’s Integrated Weight Management Approach
This development is significant because it combines pharmaceutical and behavioral strategies, potentially increasing the effectiveness of weight loss efforts. It offers a more accessible and personalized option for individuals seeking medically supported weight management, especially as demand for GLP-1 medications rises. The integration of psychological support aims to address long-term habit formation, which is critical for sustained weight management. However, the program’s success and safety depend on proper medical oversight and individual suitability.
OZEMPIC 9 MG TAB
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background of Noom’s Behavioral and Medical Integration
Noom has established itself as a leading digital health platform focused on psychology-based weight management, with millions of users worldwide. Historically, Noom offered coaching and content aimed at behavior change without medical intervention. The recent launch of the GLP-1Rx program reflects a broader trend in weight management, where pharmaceutical options like Ozempic and Zepbound have gained popularity for their efficacy in clinical trials. The move aligns with increasing public and medical interest in combining medication with lifestyle support for better outcomes.
“Noom’s new program integrates proven medications with behavioral support, offering a comprehensive approach to weight management.”
— an anonymous researcher
GLP-1 Activator Probiotic Carb Blocker Supplement for Weight Loss, Gut Health, Energy & Metabolic Support – Akkermansia, Berberine, Gymnema, Resveratrol, EGCG & Hops – Appetite Control for Women & Men
Made In USA
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Uncertainties Around Program Effectiveness and Accessibility
It remains unclear how many users will qualify for the medication, how widely the program will be adopted, and what the long-term outcomes will be. The safety and efficacy of combining Noom’s behavioral support with prescription medications in a real-world setting are still being evaluated. Additionally, regulatory and insurance coverage issues may influence accessibility and affordability for some users.
Noom GLP-1Rx program support tools
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Next Steps for Program Rollout and Evaluation
Noom is expected to monitor user outcomes closely and gather data on the program’s effectiveness and safety. The company may expand access based on initial results and user feedback. Further updates are anticipated as more users enroll and as clinical data becomes available to support or refine the program’s approach. Regulatory reviews and insurance partnerships will also shape the program’s future scope.
RENPHO Smart Scale for Body Weight, FSA&HSA Eligible, Bathroom Digital Scale with BMI, Body Fat, Bluetooth Fitness Equipment Sync with Apps, Accurate for Weight Loss, Home Use, 400 lbs – Elis 1
Smart App Sync & Fitness Integration: Easily connect your digital scale for body weight to the RENPHO Health…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
Who is eligible for Noom’s GLP-1Rx program?
Eligibility is determined through a health quiz and consultation with a licensed clinician, who assesses if the medication is appropriate based on individual health conditions.
What medications are included in the program?
The program offers access to brand-name medications like Ozempic® and Zepbound®, starting at $69 plus out-of-pocket costs, depending on insurance coverage.
How does Noom support long-term weight management?
In addition to medication, Noom provides psychological content, coaching, community support, and tools like the GLP-1 Companion to help users develop lasting healthy habits.
Are there safety concerns with using prescription GLP-1s?
Users should consult healthcare providers for personalized advice. Noom emphasizes medical oversight and ongoing monitoring to ensure safety and effectiveness.
Will insurance cover the medications?
Coverage depends on individual insurance plans; medications start at $69 plus out-of-pocket costs, and access may vary based on medical approval and insurance policies.
Source: Greatist
